The coronavirus nucleocapsid (N) protein is a viral RNA-binding protein with multiple functions in terms of virus replication and modulating cell signalling pathways. N protein is composed of three distinct regions containing RNA-binding motif(s), and appropriate signals for modulating cell signalling. The subcellular localization of severe acute respiratory syndrome coronavirus (SARS-CoV) N protein was studied. In infected cells, SARS-CoV N protein localized exclusively to the cytoplasm. In contrast to the avian coronavirus N protein, overexpressed SARS-CoV N protein remained principally localized to the cytoplasm, with very few cells exhibiting nucleolar localization. Bioinformatic analysis and deletion mutagenesis coupled to confocal microscopy and live-cell imaging, revealed that SARS-CoV N protein regions I and III contained nuclear localization signals and region II contained a nucleolar retention signal. However, cytoplasmic localization was directed by region III and was the dominant localization signal in the protein.
Severe acute respiratory disease coronavirus (SARS-CoV) is a nidovirus. One of the most abundant viral proteins produced inside a coronavirus-infected cell is the nucleocapsid (N) protein, a multifunctional phosphoprotein (Calvo et al., 2005; Chen et al., 2005; Jayaram et al., 2005) , which can bind viral RNA with high affinity to form a ribonucleocapsid structure (Risco et al., 1996) . SARS-CoV N protein (SARS-CoV-N) can also regulate cellular processes (He et al., 2003; Luo et al., 2005; Surjit et al., 2004) . Based on amino acid sequence comparisons, three conserved regions have been identified in the coronavirus N protein (Parker & Masters, 1990) , which may serve as RNA-binding sites and be involved in modulating cell signalling.
Coronavirus and the closely related arterivirus N proteins can localize to the cytoplasm, the nucleus and the nucleolus Ning et al., 2003; Rowland et al., 1999; Tijms et al., 2002; Wurm et al., 2001) , and can bind/interact with nucleolar proteins (Chen et al., 2002; Yoo et al., 2003) . The nucleolus is a dynamic subnuclear structure that is involved in ribosome subunit biogenesis and in the control of cell growth (Andersen et al., 2005; Lam et al., 2005) . Morphologically, the nucleolus can be divided into a fibrillar centre (FC), a dense fibrillar component (DFC) and an outer granular component (GC) (Thiry & Lafontaine, 2005) . Whilst nucleolar localization of N protein has been described for arterivirus and coronaviruses, the potential nuclear/nucleolar localization of the SARS-CoV-N is unknown. The cellular localization of SARS-CoV-N may inform us to its potential function in modulating cell processes.
To investigate the distribution of SARS-CoV-N in the context of virus infection, Vero cells were infected with SARS-CoV with an m.o.i. of 0?5 in a P3 facility following EU biosafety regulations, and fixed at 16, 24, 48 and 72 h postinfection (p.i.) using 8 % paraformaldehyde for analysis by indirect immunofluoresence with a rabbit polyclonal serum specific for SARS-CoV-N coupled with an Alexa 488conjugated anti-rabbit immunoglobulin G. The nucleus was stained with ToPro3 (Molecular Probes). The experiment was repeated four times and representative images are shown in Fig. 1(a) . The reason for choosing the later time points was that Qinfen et al. (2004) reported virus-like particles in the nucleus of Vero E6 cells infected with SARS-CoV at 72 h p.i. Our study indicated that whilst N protein Whilst no nucleolar localization of SARS-CoV-N was observed in infected cells, the successful detection of nucleolar proteins using antibodies can be related to the concentration of the protein within the nucleolus (Sheval et al., 2005) , in that the nucleolus is not always refractive to antibody staining. In addition, charged proteins can also migrate through cells post-fixation and become localized to the nucleus (Lundberg & Johansson, 2001 , 2002 . To address these concerns, and to investigate the subcellular localization of SARS-CoV-N in more detail, we generated vectors that expressed the protein (or parts of the protein) as a fusion with either enhanced cyan or green fluorescent protein (ECFP or EGFP, respectively). The protein could then be detected by direct fluorescence using both live-cell and confocal microscopy. As a control, we compared the subcellular localization of SARS-CoV-N with Infectious bronchitis virus N protein (IBV-N), which was located in either the cytoplasm alone or the cytoplasm and nucleolus .
SARS-CoV N gene was cloned downstream of ECFP (vector pECFPC1; Clontech), creating pECFP-SARS-CoV-N, and IBV N gene was cloned downstream of EGFP (vector pEGFPC2; Clontech), creating pEGFP-IBV-N, and when expressed in cells, resulted in fluorescent fusion proteins ECFP-SARS-CoV-N and EGFP-IBV-N, respectively. To examine the subcellular localization of SARS-CoV-N, pECFP-SARS-CoV-N and pEGFP-IBV-N were transfected (using Lipofectin) into either Vero or Cos-7 cells, and subcellular localization was followed using live-cell imaging at 24 h post-transfection. As a control, cells were transfected with vectors expressing either ECFP or EGFP alone (pECFPC1 and pEGFPC2, respectively). The data indicated that whilst ECFP and EGFP localized predominately to the cytoplasm and the nucleus, the majority of ECFP-SARS-CoV-N localized to the cytoplasm, but, in a few cases, also to apparent subnuclear structures and the nucleus, whereas EGFP-IBV-N localized to either the cytoplasm or the cytoplasm and nucleolus ( Fig. 1b) . No difference in localization of either protein was observed between Vero and Cos-7 cells (data not shown), and therefore for subsequent analysis we used Cos-7 cells, as transfection was more efficient in this cell type. Similarly, in line with our previous results the position of a fluorescent tag at either the N terminus (in this present study) or C terminus of N protein did not affect localization of the fusion protein when compared to native protein  data not shown).
The number of cells exhibiting nucleolar localization with ECFP-SARS-CoV-N appeared significantly less in comparison to EGFP-IBV-N. Therefore, we examined the subcellular localization of ECFP-SARS-CoV-N with EGFP-IBV-N over a 120 h period. Cells were transfected with either pECFP-SARS-CoV-N or pEGFP-IBV-N. In order to accurately determine the distribution of both proteins, cells were fixed at each time point and visualized using confocal microscopy. Representative confocal images for the viral proteins are shown in Fig. 1(c) for 24, 48 and 72 h post-transfection. EGFP-IBV-N localized to either the cytoplasm alone or the cytoplasm and nucleolus, with a maximum of 40 % of transfected cells exhibiting this phenotype at 48 h. In contrast, ECFP-SARS-CoV-N localized predominately to the cytoplasm alone with a maximum of 10 % of transfected cells, showing both cytoplasm and nucleolar localization at 72 h post-transfection. Localization of proteins to the nucleolus at this time point could be an artefact, in that the cells have undergone several rounds of division and nuclear and nucleolar assembly. No difference was observed in the subcellular localization of both coronavirus N proteins using either live-cell imaging or fixing cells and visualizing using confocal microscopy. Therefore, this latter technique could be used to determine subcellular localization of the N protein in combination with marker proteins.
One hypothesis to account for the difference in nucleolar localization was that ECFP-SARS-CoV-N prevented entry or retarded entry of proteins into the nucleus. For example, a number of RNA viruses that replicate in the cytoplasm can alter the nuclear pore complex to prevent either import and/or export of proteins and RNAs to the nucleus (Gustin, 2003; Gustin & Sarnow, 2001 , 2002 . To investigate this, we co-transfected cells with pECFP-SARS-CoV-N and pEGFP-IBV-N, cells were then fixed at 24, 48 and 72 h, and the subcellular localization of these fusion proteins was examined using a Zeiss LSM510 Meta confocal microscope such that the ECFP signal was unmixed from the EGFP signal. Representative cells are shown in Fig. 1(d) (note that in dual-transfected cells ECFP has been falsely coloured red). The data indicated that in dual-transfected cells, EGFP-IBV-N localized to the cytoplasm and nucleolus with the same frequency as in singly transfected cells (data not shown), and that ECFP-SARS-CoV-N did not prevent the entry of a similar protein into the nucleus.
Another possibility to account for the difference in subcellular distribution between IBV-N and SARS-CoV-N was that ECFP-SARS-CoV-N disrupted nucleolar architecture, therefore preventing or reducing its own localization to the nucleolus. A number of viruses and viral proteins can disrupt nucleolar architecture (Hiscox, 2002 (Hiscox, , 2003 , including IBV-N, although this did not prevent IBV-N from localizing to the nucleolus (Chen et al., 2002) . In addition, the previous experiment indicated that SARS-CoV-N did not inhibit localization of IBV-N. However, to investigate this possibility in more detail we examined cells that expressed ECFP-SARS-CoV-N by using confocal microscopy. Different nucleolar regions can be dissected using a combination of nucleolar marker proteins and appropriate fluorescent tag. B23 (DS-red) and nucleolin (EGFP) can be used to distinguish the FC and DFC, and EGFP-fibrillarin can be used to distinguish the GC (Fig. 2a ). In addition, phase-contrast microscopy can be used to visualize the FC, as this appears less refractive than the surrounding nucleolar regions (Fig. 2a ).
Cells were co-transfected with pECFP-SARS-CoV-N and vectors that direct the expression of EGFP-nucleolin, EGFP-fibrillarin and DS-red-B23. The confocal microscope was used to take 1?12 mm sections through cells expressing EGFP and ECFP tagged N proteins to visualize the nucleolus and the FC. Bright field microscopy (Fig. 2b ) and the nucleolar markers (EGFP-nucleolin and DS-red-B23) ( Fig. 2c and d, respectively) indicated that the FC was present in cells expressing ECFP-SARS-CoV-N. These markers also showed that there was no difference in the distribution of EGFP-nucleolin and DS-red-B23 between mock-transfected cells and those cells expressing ECFP-SARS-CoV-N. The data indicated that whilst EGFPfibrillarin was punctate in appearance in untreated cells ( Fig. 2a) , it appeared more evenly distributed in the DFC in cells co-expressing ECFP-SARS-CoV-N and EGFP-fibrillarin ( Fig. 2e ). Redistribution and/or interaction with fibrillarin has been described previously for both coronavirus and arterivirus N proteins (Chen et al., 2002; Yoo et al., 2003) .
Trafficking of proteins to the nucleus can be directed by appropriate nuclear localization signals (NLSs) including pat4, pat7 and bipartite motifs, which are groupings of arginine and lysine residues (Macara, 2001) . Export of proteins from the nucleus is mediated via nuclear export signals (NESs) perhaps best characterized by CRM-1dependent signals, which share a leucine-rich motif (Macara, 2001; Ossareh-Nazari et al., 2001) . In contrast, nucleolar retention/localization signals (NoRSs/NoLSs) are not well characterized and there is no consensus sequence (Carmo-Fonseca et al., 2000) . Marra et al. (2003) suggested that SARS-CoV-N contained a pat7 NLS in region III located between amino acid residues 369 and 376, and predicted that potential nuclear localization of SARS-CoV-N could account for the unique pathogenesis of the virus compared with other coronaviruses. However, coronaviruses representative of three known groups also contain potential NLSs in region III Wurm et al., 2001) , indeed the pat7 motif identified in SARS-CoV-N is most similar to the pat7 motif located in region III of IBV-N. Using bioinformatic analysis (la Cour et al., 2004; Nakai & Horton, 1999) , we found that SARS-CoV-N contained both pat7 and pat4, and bipartite NLSs, as well as a potential CRM-1-dependent NES (Fig. 3a) . In contrast, IBV-N contained two overlapping pat4 and pat7 motifs and a potential CRM-1-dependent NES in region III (data not shown). A number of cellular and viral proteins have multiple NLSs, which regulate their nuclear localization (Burich & Lei, 2003; Haffar et al., 2000; Luo et al., 2004; Stelz et al., 2002; Tsai & McKay, 2005) , and therefore we predicted that SARS-CoV-N may contain signals that modulate its localization.
We hypothesized that SARS-CoV-N regions I (aa 1-156) and III (aa 300-422) would direct nuclear localization, with region III being the most pronounced as it had three potential NLSs, and region II (aa 157-299) exhibiting nuclear and possibly cytoplasmic localization, as this region also contains a potential NES motif (Fig. 3a) . To test this hypothesis, we cloned the regions downstream of ECFP, creating pECFP-SARS-CoV-RI, pECFP-SARS-CoV-RII and pECFP-SARS-CoV-RIII, whose expression would lead to the synthesis of ECFP tagged to SARS-CoV-N regions I, II and III, respectively. The proteins were visualized using livecell and fixed imaging, and to visualize nucleoli proteins were imaged by confocal microscopy and staining with propidium iodide (Fig. 3b) . ECFP-SARS-CoV-RI localized predominately to the nucleus with some cytoplasmic localization, but not to the nucleolus. ECFP-SARS-CoV-RII localized predominately to nucleoli and ECFP-SARS-CoV-RIII localized to the cytoplasm, cytoplasm and nucleus, and cytoplasm and nucleoli. The most frequent being cytoplasmic localization. Although these fragments contain predicted NLSs, alternatively nuclear/nucleolar localization of these proteins could be directed by their interaction with other cellular proteins, which contain appropriate NLSs/ NoRSs. For example, nucleolar targeting of hepatitis dantigen is mediated through binding to nucleolin (Lee et al., 1998) .
Given that SARS-CoV-N region II contains a predicted NES, but was retained in the nucleolus, we examined the potential of this motif to direct nuclear export of EGFP. Aa 220-240, encompassing the predicted NES, were cloned downstream of EGFP. Expression of this plasmid in transfected cells indicated that EGFP-NES was non-functional ( Fig. 3c) and had a similar localization pattern to EGFP (Fig. 1d) . Given that SARS-CoV-N contains at least five potential NLSs, we would have predicted that deletion of aa 228-234 (encompassing the predicted NES) in the full-length SARS-CoV-N would have resulted in ECFP-SARS-CoV-N being localized to the nucleus. However, ECFP-SARS-CoV-N with the NES deletion (ECFP-N-DNES) remained localized to the cytoplasm ( Fig. 3d ), suggesting the presence of an alternative nuclear export/cytoplasmic retention signal.
Therefore, we tested the ability of the potential double pat7/ bipartite nuclear localization located in region III to direct ECFP to the nucleus and found that localization of this protein was entirely nuclear (Fig. 3e ) compared with ECFP alone (Fig. 1c) , indicating that this motif was a functional NLS. Given that ECFP-SARS-CoV-RIII localized to the cytoplasm, this region may therefore contain a dominant cytoplasmic retention/nuclear export signal that acts on the whole protein. Certainly, treatment of cells expressing ECFP-SARS-CoV-N with 8 ng leptomycin B (Sigma-Aldrich) ml 21 did not reveal any retention of ECFP-SARS-CoV-N in the nucleus (data not shown), unlike similar experiments with an arterivirus N protein (Tijms et al., 2002) .
Our data indicates that overexpressed SARS-CoV-N can localize to the cytoplasm and nucleolus, but with significantly less efficiency than IBV-N. No nucleolar localization of SARS-CoV-N was observed in virus-infected cells, and the difference between this and overexpression maybe due to a number of factors including the ability of antibodies to penetrate the nucleolus, association of N protein with other viral proteins or modification of the protein. The data suggests that region II contains a NoRS, and that whilst regions I and III contain NLSs, in the case of region III this is overridden by an undefined non-CRM-1 NES/cytoplasmic retention motif, which may be the dominant signal for localization of SARS-CoV-N inside the cell. Conformational change of the protein, perhaps through differential phosphorylation or cleavage, may expose the NLSs/NoRS with low efficiency.
